mog35-55 peptide Peptide - Mog35 55sequence Peptides MOG (35-55) Peptide: A Critical Tool in Understanding and Modeling Neurological Diseases

Mog35 55sequence The mog35-55 peptide is a crucial research reagent, primarily utilized to induce experimental autoimmune encephalomyelitis (EAE) in animal modelsExplore high-purityMOG 35–55 peptidefrom peptides&elephants — immunodominant epitope in multiple sclerosis and EAE models, ideal for T cell assays.. This peptide fragment of the Myelin Oligodendrocyte Glycoprotein (MOG) plays a significant role in neuroscience and the study of demyelinating diseases, most notably multiple sclerosis (MS)Mouse MOG (35-55) peptide. Researchers employ the MOG (35-55) fragment to investigate the complex mechanisms underlying autoimmune responses targeting the central nervous system (CNS) myelin.作者：M Rodi·2024·被引用次数：2—This work demonstrate that OM-MOG35–55 could form the basis for the development of personalized therapeutic vaccines or immunomodulatory treatments for MS.

The MOG (35-55) is a well-established immunodominant epitope of the MOG protein. MOG itself is a minor component of CNS myelin, but its significance lies in its role as a target for autoimmune attacks. When administered to susceptible animal models, such as mice and rats, the MOG 35-55 peptide can effectively induce autoantibody production and relapsing-remitting neurological diseaseMOG (35-55) | Neuronal Metabolism Peptides and .... This induced condition, EAE, closely mimics many clinical and pathophysiological features of human multiple sclerosis.MOG (35-55)peptide, mouse - 2x5 mg - SB023-2*5MG from sb-Peptide. The development of EAE in response to the MOG) (35 fragment, specifically the mog35-55 peptide, allows scientists to study the processes involved in autoimmune diseases.

The sequence of the MOG (35-55) peptide, often represented as MEVGWYRPPFSRVVHLYRNGK, is critical for its immunogenic properties. This specific peptide MOG35 fragment is known to elicit strong T and B cell responses, which are central to the autoimmune cascade leading to demyelination. The MOG 35-55 peptide is instrumental in generating these responses, leading to the characteristic plaque-like demyelination observed in EAE models. This makes it an invaluable tool for researchers seeking to understand the cellular and molecular biology of myelin damage.

Several studies highlight the utility of the MOG (35-55) peptide in EAE models.MOG (35-55) TFA (Myelin Oligodendrocyte Glycoprotein ... For instance, immunization with this peptide in C57BL/6 mice has been shown to result in ascending flaccid paralysis.MOG (35-55) (human). £85.00 1mg. SKU: NR-010 Categories: Antibodies, MyelinPeptides... The mechanism often involves the activation of MOG-specific CD4+ T cells.2024年5月31日—OM-MOG35-55suppresses antigen-specific T cell responses associated with autoimmune demyelination. Based on these results, we developed different types of ... The intravenous administration of MOG35-55 peptide has also been investigated for its potential to inhibit EAE, by suppressing key signaling pathways such as IL-17/STAT4. Furthermore, research into citrullinated human and murine MOG35–55 suggests that post-translational modifications can influence the immune response, leading to distinct disease manifestations.MOG (35-55) human – MEVGWYRPPFSRVVHLYRNGK

The MOG) 35 fragment, as well as the broader MOG 35 protein, is a target for self-reactive T cell responses, contributing to both acute and chronic autoimmune demyelination. The MOG (35-55) peptide is thus a focal point for research into potential therapeutic strategies for MS. For example, Mannan-MOG35-55 has shown promise in reversing EAE in a peptide-specific manner, even across different species' MHC class II contexts. This suggests that targeted immunomodulatory approaches based on MOG fragments could form the basis for developing personalized therapeutic vaccines or treatments for MS.

Researchers can obtain the MOG (35-55) peptide in various forms, including trifluoroacetate salts and amides, for applications in neuroscience.MOG [35-55] Peptide (Rat) When using the MOG (35-55) peptide to induce EAE, the amount of peptide needed can be a critical factor, and titration curves are often employed to optimize experimental conditions. The availability of high-purity MOG 35–55 peptide from specialized suppliers is essential for reliable and reproducible research outcomes. These peptides are typically provided as lyophilized powders and require reconstitution for use.

In summary, the mog35-55 peptide stands as a cornerstone in the research of neurological disorders characterized by demyelination.Myelin oligodendrocyte glycoprotein (MOG)peptide35-55is one of the targets of self-reactive T cell responses, leading to acute and later chronic autoimmune ... Its ability to reliably induce EAE, a model closely resembling multiple sclerosis, allows for in-depth investigation into disease pathogenesis, immune responses, and the development of novel therapeutic interventions. The 55 peptide component of this immunodominant epitope is central to these studies, offering a vital avenue for advancing our understanding of CNS autoimmune diseases.Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.